| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bd. Co-chair, President &CEO | President &CEO
1 company
Schleifer Leonard S is a Bd. Co-chair, President &CEO at REGN. Recent filings cover 0 purchases and 61 sales. Those positions are worth an estimated $165.6M at current prices.
Our model assigns Schleifer Leonard S a middling insider score of 64/100, based on 12 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +18.4%.
Schleifer Leonard S's largest disclosed position is in REGN as Bd. Co-chair, President &CEO, worth about $165.6M. The recent filings there lean toward selling, a net 465,693 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Bd. Co-chair, President &CEO | Sell10b5-1 | 25,213 | $1,015.75 | $25,610,228.70 | - | +10.6% | -49.2% | |
| Jun 6, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Bd. Co-chair, President &CEO | Sell10b5-1 | 787 | $1,015.02 | $798,820.74 | -1.2% | +17.8% | -50.7% | |
| May 17, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Bd. Co-chair, President &CEO | Sell10b5-1 | 22,830 | $979.23 | $22,355,714.15 | -4.7% | +19.7% | -39.5% | |
| May 15, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Bd. Co-chair, President &CEO | Sale+OE10b5-1 | 35,941 | $979.58 | $35,207,110.13 | -8.3% | +18.4% | -40.2% | |
| Apr 6, 2022 | REGN Regeneron Pharmaceuticals, Inc. | President &CEO | Sell | 7,114 | $710.05 | $5,051,269.17 | -38.9% | -15.8% | +17.0% | |
| Mar 31, 2022 | REGN Regeneron Pharmaceuticals, Inc. | President &CEO | Sell | 2,886 | $710.01 | $2,049,088.86 | -13.6% | -14.4% | +17.6% | |
| Aug 19, 2021 | REGN Regeneron Pharmaceuticals, Inc. | President &CEO | Sell | 210,000 | $650.51 | $136,606,300.00 | -90.8% | -2.1% | -5.7% | |
| Aug 16, 2021 | REGN Regeneron Pharmaceuticals, Inc. | President &CEO | Sell | 10,000 | $624.36 | $6,243,613.72 | -24.3% | +3.0% | +3.2% | |
| May 12, 2020 | REGN Regeneron Pharmaceuticals, Inc. | President &CEO | Sale+OE | 150,922 | $569.22 | $85,908,041.91 | -24.1% | - | - |